Auricular Vagus Stimulation and Heart Rate Variability

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorBakulev Scientific Center of Cardiovascular Surgery

About this trial

Transcutaneous electrical stimulation of the auricular vagus nerve (TENS) is a promising method of neuromodulation of the autonomic nervous system in patients with various pathologies. The use of this method requires the determination of a reliable biomarker of successful activation of the vagus nerve using TENS. Currently, most studies focus on the assessment of heart rate variability (HRV) as a marker of the functioning of the autonomic nervous system.

Despite the physiological justification of HRV as a biomarker for TENS, the data on the effects of TENS on HRV are ambiguous. In some studies, a significant decrease in the ratio of spectral characteristics (LF/HF) in active TENS was found in comparison with fictitious stimulation (sham), which indicated an increase in the parasympathetic component of HRV. However, other studies have not revealed an increase in HRV.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Sinus rhythm at the time of registration

Disqualifiers

Frequent ventricular / supraventricular extrasystole, 2d/3d degree AV Block

Taking glucocorticosteroids in the last 1 month

Taking any antiarrhythmics, except beta blockers

Severe chronic renal or liver pathology

Trial design

Design model

Parallel

Treatments tested in this trial

  • TENS

    Device

    TENS stimulation will occur within 10 minutes. HRV parameters will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.

Treatment groups

600 Participants
are divided into 2 treatment groups
Group A: Active TENSActive comparator 1 intervention
Group B: Sham TENSSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Dynamics of LF/HF

Changes in the level of LF /HF relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation

Time frame
This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.

Secondary outcomes

1

HR dynamics

Changes in the HR level relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation

Time frame
This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
2

Dynamics of SDNN

Changes in the level of SDNN relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation

Time frame
This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
3

Dynamics of IVB

Changes in the level of IVB relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation

Time frame
This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.
4

Dynamics of IC1

Changes in the level of IC1 relative to the initial and after the end of stimulation in the groups of active and fictitious stimulation. IC1 (Index Centralization) = (HF+LF)/VLF

Time frame
This parameter will be evaluated before stimulation initially at rest, in the first 5 minutes of stimulation, in the second 5 minutes of stimulation and after the end of stimulation.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bakulev Scientific Center of Cardiovascular Surgery

Lead sponsor

State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital

Collaborator

Astrakhan Federal Centre For Cardiac Surgery

Collaborator